28/06/2021 WHO launches global report on AI and health, identifying guiding principles to maximise the benefits of AI Policy watch
28/06/2021 Anavex Life Sciences announces that blarcamesine improved symptoms for people with Parkinson disease dementia Science watch
25/06/2021 During greatest public health crisis in living memory, European Commission adopts first Work Plan of new EU4Health Programme undermining key activities of European health NGOs Alzheimer Europe
25/06/2021 Three young MEPs narrate new animated video, aiming to raise awareness of Alzheimer's disease EU developments
24/06/2021 Eli Lilly receives US FDA Breakthrough Therapy designation for donanemab in AD Science watch
24/06/2021 As part of “Nature’s Building Blocks” video series, Fujirebio has created a video highlighting the importance of early diagnosis of Alzheimer's disease New publications and resources
24/06/2021 Dementias Platform UK report reveals multiple impacts of COVID-19 pandemic on dementia research COVID-19 situation
23/06/2021 Eisai and Biogen have been granted US FDA Grants Breakthrough Therapy designation for lecanemab in AD Science watch
22/06/2021 EU Parliament and Council reach political agreement on the Health Technology Assessment Regulation EU developments
21/06/2021 Dementia Lithuania forms partnership with Lithuanian Sports University Dementia in society
21/06/2021 Innovative Medicines Initiative publishes videos from its “Impact on dementia” event EU projects
21/06/2021 Results from the DIAN-TU trial show that gantenerumab reduces key biomarkers in inherited form of Alzheimer’s disease Science watch
